Alnylam Pharmaceuticals
ALNY
#817
Rank
ยฃ23.42 B
Marketcap
ยฃ175.04
Share price
0.23%
Change (1 day)
-47.12%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company